Trending...
- Slotozilla Reports Strong Growth in Q2 2026
- Eric Snyder, President and Chief Executive Officer of Keystone Consulting Engineers Named to LVB 300
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
What dentists need to know about selling their practice to a dental corporation
REDWOOD CITY, Calif. - PennZone -- More and more, we're hearing from our clients that they have either been approached by or would like to sell their practices to a corporation and work back. Understandably, this business model is increasingly popular.
"Having your cake and eating it is a very appealing concept," explains Mike Carroll, owner of dental practice transitions firm Carroll and Company. "By selling to a group and working back, owner-doctors acquire a capital sum, leave management headaches behind them, work fewer hours per week, and are able to concentrate simply on their core skill of dentistry. It doesn't hurt that corporate entities will pay very competitive prices to acquire the right practices – up to 100% of the gross revenues in some instances."
Dental practices are among the most consistently high-yield businesses in the country. This has led to large corporate dental groups or smaller, dentist-led networks becoming a far larger presence in the profession today. In the vast majority of cases, the owner-doctor will continue to work in the practice for an agreed period after the sale.
More on The PennZone
This model does not apply across the board, however. To secure a return on their investment, corporations are looking for profitable, well-maintained practices with five or more operatories grossing upwards of $750,000 a year. Practices with four or fewer operatories, with lower gross revenues or above-average overhead, will tend to sell to an individual buyer. (Even here, though, a merger may be the way forward: there's a growing trend for dentists to acquire two or more practices.)
Our clients come to us with many questions and concerns about how to navigate the complexities of sale to a corporate entity.
In our experience, the following five questions will start the conversation along the right lines and lead to a successful result.
- For how long will I be contracted to work back? If I leave before the contracted period will there be a penalty?
More on The PennZone
- How will my compensation be structured –a percentage of production/collections, profit share, or a combination?
- Will any of the purchase price be held back to comply with post-sale employment requirements?
- Am I willing to work as an employee? Can I step away from the mindset of an owner?
- What is the philosophy of treatment of the corporate entity?
For more information about this or other issues concerning transitioning your dental practice, or for a free copy of our magazine, please contact Carroll and Company at 650-362-7004, extension 101 or 102, or email us at dental@carrollandco.info.
"Having your cake and eating it is a very appealing concept," explains Mike Carroll, owner of dental practice transitions firm Carroll and Company. "By selling to a group and working back, owner-doctors acquire a capital sum, leave management headaches behind them, work fewer hours per week, and are able to concentrate simply on their core skill of dentistry. It doesn't hurt that corporate entities will pay very competitive prices to acquire the right practices – up to 100% of the gross revenues in some instances."
Dental practices are among the most consistently high-yield businesses in the country. This has led to large corporate dental groups or smaller, dentist-led networks becoming a far larger presence in the profession today. In the vast majority of cases, the owner-doctor will continue to work in the practice for an agreed period after the sale.
More on The PennZone
- Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
- RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
- Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History
- New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
- Grace Montessori School Earns Prestigious American Montessori Society Accreditation
This model does not apply across the board, however. To secure a return on their investment, corporations are looking for profitable, well-maintained practices with five or more operatories grossing upwards of $750,000 a year. Practices with four or fewer operatories, with lower gross revenues or above-average overhead, will tend to sell to an individual buyer. (Even here, though, a merger may be the way forward: there's a growing trend for dentists to acquire two or more practices.)
Our clients come to us with many questions and concerns about how to navigate the complexities of sale to a corporate entity.
In our experience, the following five questions will start the conversation along the right lines and lead to a successful result.
- For how long will I be contracted to work back? If I leave before the contracted period will there be a penalty?
More on The PennZone
- Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
- Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
- CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
- NaturismRE expands international research programme with Health & Wellbeing Survey
- L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach
- How will my compensation be structured –a percentage of production/collections, profit share, or a combination?
- Will any of the purchase price be held back to comply with post-sale employment requirements?
- Am I willing to work as an employee? Can I step away from the mindset of an owner?
- What is the philosophy of treatment of the corporate entity?
For more information about this or other issues concerning transitioning your dental practice, or for a free copy of our magazine, please contact Carroll and Company at 650-362-7004, extension 101 or 102, or email us at dental@carrollandco.info.
Source: Carroll and Company
0 Comments
Latest on The PennZone
- Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- Tina Hasselbusch, Turnstone Creative Co-founder and Chief Executive Officer, Named to LVB 300
- Pittsburgh Family Law Attorneys at Pollock Begg Earn Top Honors in 2027 Best Lawyers Guide
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
- Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
- Slotozilla Reports Strong Growth in Q2 2026
- Eric Snyder, President and Chief Executive Officer of Keystone Consulting Engineers Named to LVB 300
- Philadelphia's Girls Anthem to Host The Locker Room Experience Pop-Up for Young Women
- Flexible Plan Investments Names Carl Resnick President
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
- No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
- The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
- Sharon Pinkenson Chosen as Philly Girl Top 40 Winner
- Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
- Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
- Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention

